Literature DB >> 20184370

Development of new fluorescent xanthines as kinase inhibitors.

Donghee Kim1, Hwiseok Jun, Hyunseung Lee, Soon-Sun Hong, Sungwoo Hong.   

Abstract

An efficient and versatile synthetic approach for the preparation of highly substituted xanthine derivatives has been developed by a combination of direct N7- and C8-arylation. With this method, diverse xanthine analogues were prepared and potent kinase inhibitors could be identified. For example, compound 8a inhibits PI3Ks and proliferation in T47D tumor cells. In addition, these xanthine-based kinase inhibitors exhibited significant fluorescence emission in a concentration-dependent response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184370     DOI: 10.1021/ol100011n

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  8 in total

1.  Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.

Authors:  Sean P Arlauckas; Anatoliy V Popov; Edward J Delikatny
Journal:  Mol Cancer Ther       Date:  2014-07-15       Impact factor: 6.261

2.  Palladium- and copper-mediated N-aryl bond formation reactions for the synthesis of biological active compounds.

Authors:  Carolin Fischer; Burkhard Koenig
Journal:  Beilstein J Org Chem       Date:  2011-01-14       Impact factor: 2.883

Review 3.  Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors.

Authors:  S J Shuttleworth; F A Silva; A R L Cecil; C D Tomassi; T J Hill; F I Raynaud; P A Clarke; P Workman
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 4.  Fluorescent kinase inhibitors as probes in cancer.

Authors:  Syed Muhammad Usama; Bosheng Zhao; Kevin Burgess
Journal:  Chem Soc Rev       Date:  2021-07-22       Impact factor: 60.615

5.  HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy.

Authors:  Ju-Hee Lee; Kyung Hee Jung; Hyunseung Lee; Mi Kwon Son; Sun-Mi Yun; Sung-Hoon Ahn; Kyeong-Ryoon Lee; Soyoung Lee; Donghee Kim; Sungwoo Hong; Soon-Sun Hong
Journal:  Oncotarget       Date:  2014-10-30

Review 6.  Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents.

Authors:  Yu Liu; Wen-Zhu Wan; Yan Li; Guan-Lian Zhou; Xin-Guang Liu
Journal:  Oncotarget       Date:  2017-01-24

7.  A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding.

Authors:  Cassandra L Fleming; Patrick A Sandoz; Tord Inghardt; Björn Önfelt; Morten Grøtli; Joakim Andréasson
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-05       Impact factor: 15.336

Review 8.  Xanthine scaffold: scope and potential in drug development.

Authors:  Nivedita Singh; Ashwinee Kumar Shreshtha; M S Thakur; Sanjukta Patra
Journal:  Heliyon       Date:  2018-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.